Clinical Trial Update: Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized controlled trial of topical eflornithine for pseudofolliculitis barbae was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudofolliculitis Barbae

Drugs mentioned

• eflornithine topical (eflornithine)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Pseudofolliculitis Barbae | Phase 4 | Status: TERMINATED